Congenital generalized lipodystrophy accompanied by cystic angiomatosis.
D000052:Acanthosis Nigricans / Q000150:complications; D000293:Adolescent; D000328:Adult; D001741:Black or African American; D000798:Angiomatosis / Q000150:complications / Q000235:genetics*; D001481:Basal Metabolism; D001798:Blood Proteins / Q000032:analysis; D001845:Bone Cysts / Q000150:complications; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D048909:Diabetes Complications; D005149:Facial Expression; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006529:Hepatomegaly / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D007329:Insulin Antagonists; D007333:Insulin Resistance; D008607:Intellectual Disability / Q000150:complications; D008055:Lipids / Q000097:blood; D008060:Lipodystrophy / Q000150:complications / Q000235:genetics*; D008297:Male; D009132:Muscles / Q000473:pathology; D010048:Ovarian Cysts / Q000150:complications; D010375:Pedigree; D010913:Pituitary-Adrenal System / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011859:Radiography
D001798:Blood Proteins; D007329:Insulin Antagonists; D008055:Lipids; D013006:Growth Hormone